Nirtek is developing a medical device that utilizes near-infrared laser technology to detect unstable coronary plaques, which are critical indicators of potential heart attacks. This technology aims to enhance early diagnosis and intervention, ultimately preventing life-threatening cardiovascular events.
Funding
$50K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting unstable coronary plaques, a key indicator of potential heart attacks, may not provide sufficient accuracy or speed for timely intervention. This can lead to delayed diagnoses and increased risk of life-threatening cardiovascular events.
Solution
Nirtek is developing a medical device that utilizes near-infrared laser technology to improve the detection of unstable coronary plaques. The device aims to provide a more accurate and rapid assessment of plaque vulnerability, enabling earlier and more effective intervention strategies. By identifying high-risk plaques before they rupture, the technology has the potential to significantly reduce the incidence of heart attacks and improve patient outcomes. The device is designed to integrate seamlessly into existing clinical workflows, providing clinicians with real-time data to inform treatment decisions.
Target Audience
The primary target audience includes cardiologists, interventional radiologists, and hospitals specializing in cardiovascular care.
Features
- Near-infrared laser technology for enhanced plaque characterization
- Real-time data analysis for immediate risk assessment
- Integration with existing cardiac catheterization systems
- High sensitivity and specificity for detecting vulnerable plaques